Search

everythinglearnresearchcommunity

for

Search:↓

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Thyroid issues can cause alopecia areata.

Compound glycyrrhizin with conventional treatments is effective and safe for hair regrowth in alopecia areata.

Nepalese patients with hair loss, especially women and those with androgenetic alopecia, experience a significant decrease in quality of life.

The study helps doctors use patient images to understand and apply SALT scores for treating severe alopecia areata.

Trichoscopy helps diagnose and manage hair and scalp disorders in children.

Hair loss can significantly impact a person's mental health, causing issues like anxiety and depression, and stress can trigger hair loss.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

The study found that alopecia areata and hypothyroidism increase the risk of each other, but androgenetic alopecia and hypothyroidism do not.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Six genetic conditions are often linked to complete scalp hair loss in children.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

Some alopecia treatments might help treat COVID-19, but more research is needed.

Bacteroides fragilis and Microbacterium sp. T32 may be linked to autoimmune activity in Hashimoto's thyroiditis and alopecia areata.

Laser-assisted drug delivery is generally safe with mostly mild side effects.

COVID-19 can worsen autoimmune skin diseases and increase their occurrence.

Some COVID-19 pneumonia patients in Veracruz, Mexico, had skin issues, with reversible hair loss linked to disease severity.

The conference highlighted new treatments and research in pediatric skin conditions, emphasizing collaboration and innovation.

COVID-19 can cause long-term skin problems and has changed how skin doctors work.

JAK/STAT inhibitors show promise for skin diseases but aren't yet approved.

Collaboration and innovation are key to developing effective, safe hair loss treatments.

Botulinum Neurotoxin-A can treat acne, oily skin, rosacea, hair loss, prevent scars, relieve nerve pain, reduce excessive sweating, and manage psoriasis, but more trials are needed to confirm its effectiveness.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Atopic dermatitis increases the risk of some autoimmune diseases.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Phenol is effective for skin treatments but poses serious health risks and must be used cautiously by trained doctors.